Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Crux Biomedical Vena Cava Filter Study - United States

ClinicalTrials.gov ID: NCT01120509

Public ClinicalTrials.gov record NCT01120509. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 2

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if the Crux Vena Cava Filter System is safe and effective in preventing pulmonary embolism.

Study identification

NCT ID
NCT01120509
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Crux Biomedical
Industry
Enrollment
88 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2010 (Type not available)
Primary completion
Jun 2011 (Actual)
Completion
Jan 2012 (Actual)
Last update posted
Jun 30, 2014

2010 – 2012

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
St. Joseph's Hospital Orange California 92868 —
University of California at Irvine Medical Center Orange California 92868 —
Univeristy of California at Davis Medical Center Sacramento California 95817 —
Christiana Care Newark Delaware — —
University of Florida Medical Center Gainesville Florida 32610 —
Atlanta Medical Center Atlanta Georgia 30312 —
University Hospital Augusta Georgia 30901 —
University of Chicago Medical Center Chicago Illinois 60637 —
St. Francis Hospital Peoria Illinois 61637 —
Anne Arundel Medical Center Annapolis Maryland 21401 —
Albany Medical Center Albany New York 12208 —
Upstate Medical Center Syracuse New York 13210 —
University of North Carolina Medical Center Chapel Hill North Carolina 27599 —
Jobst Vascular Institute Toledo Ohio 43606 —
Hershey Medical Center Hershey Pennsylvania 17033 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
University of Virginia Medical Center Charlottesville Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01120509, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 30, 2014 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01120509 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →